The Biosintética Farmacêutica Ltda., acquired by Aché Laboratórios Farmacêuticos SA in 2005, is among the first laboratories to obtain generic license in Brazil and among the largest of category in the country. The company produces high quality medicines and makes them available at affordable prices to the population.
In the forms of tablets, capsules, syrups, dragees, ointments, creams, suspensions and injectables, the Biosintética products act in the prevention and treatment of pathologies related to more than 30 specialties including cardiology, dermatology, gastroenterology, orthopedics, respiratory, nervous system central and oncology.
Industrial complex, located in Jurubatuba (South Zone of São Paulo), produces exclusive molecules: tramadol + paracetamol, mesylate Ergoloid and ibandronate sodium. There are still rivastigmine, valsartan and simethicone, among other consecrated in combating disturbances to health.
With constant investment in bioequivalence and pharmaceutical equivalence tests as well as in high-tech equipment, Biosintética assures the public OTC drugs and prescription with the same effectiveness and safety of reference products.
Our approximately 950 employees (including Sales Force) work constantly to doctors, pharmacists and clerks interact in an important process of valuing life: to bring health and wellness to consumers.
Learn more about the Aché.